Evidence for macrocyclic lactone anthelmintic resistance in dirofilaria immitis

Topics in Companion Animal Medicine

Volumn 26, Issue 4, 2011, Pages 186-192

  Geary, Timothy G ^a   Bourguinat, Catherine ^a   Prichard, Roger K ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Anthelmintic resistance; Dirofilaria immitis; Heartworm; Ivermectin; Macrocyclic lactone

Indexed keywords

ANTIFILARIAL AGENT; MACROLIDE;

ANIMAL; ARTICLE; DIROFILARIA IMMITIS; DIROFILARIASIS; DOG; DOG DISEASE; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; GENETICS;

ANIMALS; DIROFILARIA IMMITIS; DIROFILARIASIS; DOG DISEASES; DOGS; DRUG RESISTANCE; FILARICIDES; MACROLIDES; PARASITIC SENSITIVITY TESTS;

EID: 83055196519     PISSN: 19389736     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.tcam.2011.09.004     Document Type: Article

References (53)

1. Geary T.G., Mackenzie C.D. Progress and challenges in the discovery of macrofilaricidal drugs. Expert Op Anti-infect Ther 2011, 9:681-695.
2. Ottesen E.A., Hooper P.J., Bradley M., et al. The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS-Negl Trop Dis 2008, 2:e317.
3. Thylefors B. The Mectizan Donation Program. Ann Trop Med Parasitol 2008, 102(Suppl 1):39-44.
4. McCall J.W., Genchi C., Kramer L.H., et al. Heartworm disease in animals and humans. Adv Parasitol 2008, 66:193-285.
5. Bowman D.D., Atkins C.E. Heartworm biology, treatment and control. Vet Clin North Am (Small Anim Pract) 2009, 39:1127-1158.
6. Hampshire V.A. Evaluation of efficacy of heartworm preventive products at the FDA. Vet Parasitol 2005, 133:191-195.
7. Conder G.A., Campbell W.C. Chemotherapy of nematode infections of veterinary importance, with special reference to drug resistance. Adv Parasitol 1995, 35:1-84.
8. Kaplan R.M. Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol 2004, 20:477-481.
9. Wolstenholme A.J., Fairweather I., Prichard R.K., et al. Drug resistance in veterinary helminths. Trends Parasitol 2004, 20:469-476.
10. Coles G.C., Jackson F., Pomroy W.E., et al. The detection of anthelmintic resistance in nematodes of veterinary importance. Vet Parasitol 2006, 136:167-185.
11. Fleming S.A., Craig T., Kaplan R.M., et al. Anthelmintic resistance of gastrointestinal parasites in small ruminants. J Vet Intern Med 2006, 20:435-444.
12. Sutherland I.A., Leathwick D.M. Anthelmintic resistance in nematode parasites of cattle: a global issue?. Trends Parasitol 2011, 27:176-181.
13. Matthews J.B. Facing the threat of equine parasitic disease. Equine Vet J 2011, 43:126-132.
14. Aguinaldo A.M., Turbeville J.M., Linford L.S., et al. Evidence for a clade of nematodes, arthropods and moulting animals. Nature 1997, 387:489-493.
15. Osei-Atweneboana M.Y., Eng J.K., Boakye D.A., et al. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 2007, 369:2021-2029.
16. Osei-Atweneboana M.Y., Awadzi K., Attah S.K., et al. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis 2011, 5:e998.
17. Churcher T.S., Pion S.D., Osei-Atweneboana M.Y., et al. Identifying suboptimal responses to ivermectin in the treatment of river blindness. Proc Natl Acad Sci U S A 2009, 106:16716-16721.
18. Eng J.K., Prichard R.K. A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients. Mol Biochem Parasitol 2005, 142:193-202.
19. Ardelli B.F., Prichard R.K. Reduced genetic variation of an Onchocerca volvulus ABC transporter gene following treatment with ivermectin. Trans R Soc Trop Med Hyg 2007, 101:1223-1232.
20. Bourguinat C., Ardelli B.F., Pion S.D., et al. P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol Biochem Parasitol 2008, 158:101-111.
21. Churcher T.S., Schwab A.E., Prichard R.K., et al. An analysis of genetic diversity and inbreeding in Wuchereria bancrofti: implications for the spread and detection of drug resistance. PLoS Negl Trop Dis 2008, 2:e211.
22. Gilleard J.S., Beech R.N. Population genetics of anthelmintic resistance in parasitic nematodes. Parasitology 2007, 134:1133-1147.
23. Prichard R.K., Roulet A. ABC transporters and beta-tubulin in macrocyclic lactone resistance: prospects for marker development. Parasitology 2007, 134:1123-1132.
24. Beech R.N., Skuce P., Bartley D.J., et al. Anthelmintic resistance: markers for resistance, or susceptibility?. Parasitology 2011, 138:160-174.
25. Devaney E., Howells R.E. The microfilaricidal activity of ivermectin in vitro and in vivo. Tropenmed Parasitol 1984, 35:47-49.
26. Vande Waa E.A., Bennett J.L., Williams J.F., et al. Anti-filarial effects of nine quinoline-containing drugs on adult filariae in vitro. J Parasitol 1989, 75:367-372.
27. Bowen J.M., Vitayavirasak B. Contractile activity and motility responses of the dig heartworm Dirofilaria immitis to classical anthelmintics and other compounds. Vet Parasitol 2005, 134:183-188.
28. Geary T.G., Woo K., McCarthy J.S., et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol 2010, 40:1-13.
29. Geary TG, Moreno Y: Macrocyclic lactone anthelmintics: spectrum of activity and mechanism of action. Curr Pharm Biotech (in press).
30. Moreno Y., Nabhan J.F., Solomon J., et al. Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi. Proc Natl Acad Sci U S A 2010, 107:20120-20125.
31. Blagburn B.L., Dillon A.R., Arther R.G., et al. Comparative efficacy of four commercially available heartworm preventative products against the MP3 laboratory strain of Dirofilaria immitis. Vet Parasitol 2011, 176:189-194.
32. Snyder D.E., Wiseman S., Cruthers L.R., et al. Ivermectin and milbemycin oxime in experimental adult heartworm (Dirofilaria immitis) infection of dogs. J Vet Intern Med 2011, 25:61-64.
33. Bourguinat C., Keller K., Prichard R.K., et al. Genetic polymorphism in Dirofilaria immitis. Vet Parasitol 2011, 176:368-373.
34. Bourguinat C., Keller K., Blagburn B., et al. Correlation between loss of efficacy of macrocyclic lactone heartworm preventatives and P-glycoprotein genotype. Vet Parasitol 2011, 176:374-381.
35. Bourguinat C., Keller K., Bhan A., et al. Evidence of macrocyclic lactone resistance in Dirofilaria immitis: a case report. Vet Parasitol 2011, 181:388-392.
36. Belanger D.H., Perkins S.L., Rockwell R.F. Inference of population structure and patterns of gene flow in canine heartworm (Dirofilaria immitis). J Parasitol 2011, 97:602-609.
37. Heartworm preventive resistance: is it possible? American Heartworm Society, Accessed September 25, 2011. http://www.mdvma.org/newsletter/2011/spring/heartworm.pdf.
38. Campbell W.C. Efficacy of the avermectins against filarial parasites: a short review. Vet Res Commun 1982, 5:251-262.
39. Campbell W.C. Ivermectin and heartworm. Semin Vet Med Surg (Small Anim) 1987, 2:48-55.
40. Brown K.R., Ricci F.M., Ottesen E.A. Ivermectin: effectiveness in lymphatic filariasis. Parasitology 2000, 121:S133-S146.
41. Basáñez M.-G., Pion S.D.S., Boakes E., et al. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:310-322.
42. McCall J.W. The safety-net story about macrocyclic lactone heartworm preventatives: a review, an update and recommendations. Vet Parasitol 2005, 133:197-206.
43. McCall J.W., Genchi C., Kramer L., et al. Heartworm and Wolbachia: therapeutic implications. Vet Parasitol 2008, 158:204-214.
44. Prichard R.K. Is anthelmintic resistance a concern for heartworm control?. What can we learn from the human filariasis control programs?. Vet Parasitol 2005, 133:243-253.
45. 1a against microfilariae of Dirofilaria immitis. Am J Vet Res 1979, 40:1031-1032.
46. Jackson R.F., Seymour W.G. Efficacy of avermectins against microfilariae of Dirofilaria immitis. Proceedings of the Heartworm Symposium 1980, 131-138.
47. Plue R.E., Seward R.L., Acre K.E., et al. Clearance of Dirofilaria immitis microfilariae in dogs using 200 mkg/kg ivermectin subcutaneously. Proceedings of the Heartworm Symposium 1983, 153-160.
48. Blair L.S., Malatesta P.F., Ewanciw V. Dose-response study of ivermectin against Dirofilaria immitis microfilariae in dogs with naturally acquired infections. Am J Vet Res 1983, 44:475-477.
49. McManus E.C., Pulliam J.D. Histopathologic features of canine heartworm microfilarial infection after treatment with ivermectin. Am J Vet Res 1984, 45:91-97.
50. Suderman M.T., Craig T.M. Efficacy of ivermectin against Dirofilaria immitis microfilariae in naturally infected dogs. Am J Vet Res 1984, 45:1031-1032.
51. Knight D.H., Campbell W.C., Weiner D.J., et al. Microfilaricidal efficacy of ivermectin in adulticide treated and untreated heartworm infected dogs. Proceedings of the Heartworm Symposium 1986, 19-27.
52. Lok J.B., Knight D.H., Ramadan E.-S.I. Effects of ivermectin on embryogenesis in Dirofilaria immitis: age structure and spatial distribution of intrauterine forms as a function of dosage and time posttreatment. Proceedings of the Heartworm Symposium 1989, 85-94.
53. Sasaki Y., Kitagawa H. Effects of milbemycin D on microfilarial number and reproduction of Dirofilaria immitis in dogs. J Vet Med Sci 1993, 55:763-769.